Predictive Oncology (NASDAQ:POAI) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why

Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $6.79 and traded as low as $6.2849. Predictive Oncology shares last traded at $6.4050, with a volume of 241,814 shares trading hands.

Predictive Oncology Stock Performance

The business has a 50 day moving average price of $9.60 and a two-hundred day moving average price of $6.79. The company has a market cap of $21.74 million, a P/E ratio of -0.47 and a beta of 1.35.

About Predictive Oncology

(Get Free Report)

Predictive Oncology Inc. is a biotechnology company focused on applying artificial intelligence and machine learning to cancer drug discovery. Its approach combines computational tools with tumor samples and related biological and drug-response data to help researchers assess potential treatments and identify promising drug candidates. The company’s PEDAL platform is designed to analyze these data and model how tumors may respond to different compounds. Through its Helomics-related operations, Predictive Oncology has also offered laboratory services and access to tumor-based research resources for pharmaceutical and biotechnology partners.

Featured Stories

Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.